Eyebright Medical Technology (Beijing) Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000041J5
CNY
50.81
0.2 (0.4%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
398.24
338.29
357.72
429.51
357.18
334.76
389.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
398.24
338.29
357.72
429.51
357.18
334.76
389.55
Raw Material Cost
153.40
152.62
143.71
161.49
141.03
143.70
159.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.82
6.00
5.22
4.90
6.86
5.76
6.16
Selling and Distribution Expenses
120.70
106.87
107.33
106.19
92.96
86.57
75.35
Other Expenses
1.28
1.65
1.32
1.44
1.61
1.94
2.00
Total Expenditure (Excl Depreciation)
292.69
281.97
269.50
287.03
256.93
255.47
260.57
Operating Profit (PBDIT) excl Other Income
105.60000000000001
56.3
88.2
142.5
100.19999999999999
79.3
129
Other Income
3.63
5.59
4.08
8.42
12.48
5.77
6.38
Operating Profit (PBDIT)
104.80
21.34
134.50
187.25
148.68
113.75
169.95
Interest
5.82
6.00
5.22
4.90
6.86
5.76
6.16
Exceptional Items
-0.32
0.08
0.03
-0.44
0.54
0.10
0.15
Gross Profit (PBDT)
244.84
185.67
214.01
268.02
216.15
191.05
230.45
Depreciation
0.00
48.35
48.35
41.55
41.55
38.76
38.76
Profit Before Tax
98.65
-32.94
80.95
140.36
100.80
69.32
125.18
Tax
12.84
4.89
9.11
23.42
11.26
-13.76
20.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
89.28
-21.99
76.85
120.75
92.56
70.81
109.55
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
89.28
-21.99
76.85
120.75
92.56
70.81
109.55
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.47
-16.05
-5.11
-3.68
-2.74
12.23
-4.68
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
85.81
-38.03
71.74
117.07
89.81
83.04
104.87
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,863.88
2,788.74
2,810.51
2,789.34
2,448.03
2,409.50
2,330.29
Earnings per share (EPS)
0.46
-0.11
0.4
0.63
0.49
0.37
0.58
Diluted Earnings per share
0.46
-0.11
0.4
0.63
0.49
0.37
0.58
Operating Profit Margin (Excl OI)
25.4%
-9.64%
22.94%
31.96%
26.5%
20.68%
32.04%
Gross Profit Margin
24.77%
4.56%
36.15%
42.35%
39.85%
32.29%
42.08%
PAT Margin
22.42%
-6.5%
21.48%
28.11%
25.91%
21.15%
28.12%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 17.71% vs -5.42% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 325.79% vs -153.00% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 544.59% vs -87.96% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -3.33% vs 15.38% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Eyebright Medical Technology (Beijing) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
398.24
0
398.24
Other Operating Income
0.00
0.00
0.00
Total Operating income
398.24
0
398.24
Raw Material Cost
153.40
0
153.40
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.82
0
5.82
Selling and Distribution Expenses
120.70
0
120.70
Other Expenses
1.28
0.00
1.28
Total Expenditure (Excl Depreciation)
292.69
0
292.69
Operating Profit (PBDIT) excl Other Income
105.55
0.00
105.55
Other Income
3.63
0
3.63
Operating Profit (PBDIT)
104.80
0
104.80
Interest
5.82
0
5.82
Exceptional Items
-0.32
0
-0.32
Gross Profit (PBDT)
244.84
0
244.84
Depreciation
0.00
0
0.00
Profit Before Tax
98.65
0
98.65
Tax
12.84
0
12.84
Provisions and contingencies
0
0
0.00
Profit After Tax
89.28
0
89.28
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
89.28
0
89.28
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.47
0
-3.47
Other related items
0.00
0.00
0.00
Consolidated Net Profit
85.81
0
85.81
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,863.88
0
2,863.88
Earnings per share (EPS)
0.46
0
0.46
Diluted Earnings per share
0.46
0
0.46
Operating Profit Margin (Excl OI)
25.40%
0%
0.00
25.40%
Gross Profit Margin
24.77%
0%
0.00
24.77%
PAT Margin
22.42%
0%
0.00
22.42%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.82 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 17.71% vs -5.42% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 11.48% vs 15.08% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.58 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 325.79% vs -153.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -4.45% vs -8.83% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.12 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 544.59% vs -87.96% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -25.70% vs -7.60% in Mar 2025

Quarterly - Interest
Interest 0.58 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -3.33% vs 15.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -15.94% vs 50.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.40%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025